Targeted therapy for lung cancer, Paris 2015

About
Research Seminars gather a small number (20 to 100) of well-established and preferably young investigators to address scientific topics in depth and help break new ground. Research Seminars take place over two days in easy-to-reach European cities. They are scientific Seminars involving recently published work and research in progress. Participation is fully supported by the budget granted by the ERS.
About  Show

Background
The main aim of this seminar was to promote the exchange of knowledge and the interaction between basic scientists and clinicians as well as between the different research groups that are currently working on targeted therapy of lung cancer. The participants evaluated advance in lung-cancer targeted therapy so far and defined topics of future research projects aimed to improve the efficacy of targeted drugs as well as their availability to larger subgroups of lung cancer patients.
Background  Show

Download all media Download all media
 [+]  PDF journal article, handout or slides Molecular abnormalities and histopathology in lung cancer
Philipp Schnabel (Homburg/Saar, Germany)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  PDF journal article, handout or slides PDF journal article, handout or slides How to get the tissue for which issues?
Fernando Gamarra (Munich, Germany)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  PDF journal article, handout or slides Slide presentation Liquid biopsy as an alternative
Rafael Rosell (Badalona, Spain)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  PDF journal article, handout or slides PDF journal article, handout or slides Tyrosine Kinase Transmembrane Receptor alterations in NSCLC
Nicolas Girard (Lyon, France)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  PDF journal article, handout or slides PDF journal article, handout or slides EGFR TKI in the current clinical practice
Jacques Cadranel (Paris, France)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  PDF journal article, handout or slides Slide presentation Failure of EGFR TKI treatment: mechanisms and current strategies?
Rafael Rosell (Badalona, Spain)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  PDF journal article, handout or slides PDF journal article, handout or slides Target other gene point mutations: HER2 and rare EGFR mutations
Federico Cappuzzo (Livorno, Italy)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Slide presentation Target gene rearrangements: ALK, ROS and RET
Luis Paz-Ares (Seville, Spain)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  PDF journal article, handout or slides PDF journal article, handout or slides Target amplification/protein surexpression: c met and FGFR
Nicolas Girard (Lyon, France)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  PDF journal article, handout or slides Slide presentation 10 What have we learn from rebiospy studies?
Anne-Pascale Meert (Brussels, Belgium)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  PDF journal article, handout or slides Slide presentation 11 What can we learn from animal models?
Christine Lovly (Nashville, United States of America)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  PDF journal article, handout or slides Slide presentation 12 What could we learn from ongoing therapeutic trials?
David Planchard (Roussy-Villejuif, France)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 No content
  made available
13 Identifying the target
Céline Mascaux (Toronto, Canada)
 [+]  PDF journal article, handout or slides Slide presentation 14 Optimizing the target therapy development
Jacques Cadranel (Paris, France)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  PDF journal article, handout or slides Slide presentation 15 Ongoing studies
Thierry Berghmans (Brussels, Belgium)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite